Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-22-050074

Chief Financial Officer bought 15,000 shares at $2.58 ($38,651)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Byam Rebecca Chief Financial Officer 2022-09-14 Purchase +15,000 $2.58 $38,651 327,952 D
Open-market purchases · 15,000 sh · avg $2.58 · $38,651
Loading xslF345X03/doc4.xml…